Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Auditor change
Director departure
Appointed director
LifeMD, Inc. (CVLB) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 SC 13G Divisadero Street Capital Management, LP reports a 5.3% stake in LifeMD, Inc.
08/10/2023 8-K Investor presentation
Docs: "Investor Presentation dated August 2023"
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/31/2023 8-K Quarterly results
07/14/2023 8-K Quarterly results
07/07/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
06/29/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/12/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/28/2023 ARS Form ARS - Annual Report to Security Holders:
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/27/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
03/22/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"AVENUE VENTURE OPPORTUNITIES FUND, L.P., a Delaware limited partnership as administrative agent and collateral agent and as a lender LOAN AND SECURITY AGREEMENT Borrower, Lenders and Agent anticipate entering into one or more transactions pursuant to which each Lender agrees to make available to Borrower a loan facility governed by the terms and conditions set forth in this document and one or more Supplements executed by Borrower, Lenders and Agent which incorporate this document by reference. Each Supplement constitutes a supplement to and forms part of this document, and will be read and construed as one with this document, so that this document and the Supplement constitute a single agreement between the parties . Accordingly, the parties agree as follows: ARTICLE 1 - INTERPRETATION 1....",
"“Loan and Security Agreement”), by and among Borrower, Lenders and Agent. All capitalized terms used in this Supplement and not otherwise defined in this Supplement have the meanings ascribed to them in Article 11 of the Loan and Security Agreement, which is incorporated in its entirety into this Supplement. In the event of any inconsistency between the provisions of the Loan and Security Agreement and this Supplement, this Supplement is controlling.",
"EXHIBIT A",
"PROMISSORY NOTE",
"LifeMD, Inc. Announces Closing of New $40 Million Credit Facility"
03/22/2023 10-K Annual Report for the period ended December 31, 2022
02/10/2023 8-K Quarterly results
02/06/2023 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
12/21/2022 8-K Quarterly results
11/14/2022 8-K Quarterly results
11/10/2022 10-Q Quarterly Report for the period ended September 30, 2022
09/20/2022 8-K Appointed a new director
Docs: "DIRECTOR AGREEMENT This DIRECTOR AGREEMENT is made as of September _ 14 _, 2022 , by and between LifeMD, Inc., a Delaware corporation , and Robert Jindal, an individual with an address of 15040 Audubon Lakes Drive, Baton Rouge, LA 70810 . WHEREAS, the Company and the Director desire to enter with respect to the appointment of the Director; WHEREAS, the Director is willing to serve the Company on the terms set forth herein and in accordance with the provisions of this Agreement. NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties hereto agree as follows: 1. Position . Subject to the terms and provisions of this Agreement, the Director hereby agrees to serve the Company as a member of the Company’ s Board of Directors , upon the terms and conditions hereina...",
"RESTRICTED STOCK AWARD AGREEMENT DIRECTORS THIS RESTRICTED STOCK AWARD is granted as of Sept. 14, 2022 , and reflected in this RESTRICTED STOCK AWARD AGREEMENT between LifeMD, Inc. , and Robert Jindal . WHEREAS, the Company desires to grant the Director, shares of the Company’ s Common Stock, $0.01 par value , subject to certain restrictions as set forth in this Agreement , pursuant to the LifeMD, Inc. 2020 Equity Incentive Plan ; WHEREAS, the Board of Directors has determined that it would be to the advantage and best interest of the Company and its stockholders to grant the Shares herein to the Director; and NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 1. Grant of Restricted Shares . Subjec...",
"LIFEMD, INC. NON-QUALIFIED STOCK OPTION AGREEMENT DIRECTOR THIS NON-QUALIFIED STOCK OPTION is granted as of Sept. 14, 2022 , and reflected in this NON-QUALIFIED STOCK OPTION AGREEMENT by and between LifeMD, Inc. and Robert Jindal . WHEREAS, pursuant to the authority of the Board of Directors , the Company has granted the Optionee the right to purchase common stock, $0.01 par value per share of the Company pursuant to stock options, at not less than 100% of fair market value, granted under the LifeMD, Inc. 2020 Equity and Incentive Plan, approved by the Board . NOW THEREFORE, in consideration of the mutual covenants and promises hereafter set forth and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows: 1. ...",
"LifeMD Appoints Bobby Jindal to the Board of Directors NEW YORK, September 20, 2022 — LifeMD, Inc . , a leading direct-to-patient telehealth company, is pleased to announce its appointment of Bobby Jindal, the 55th Governor of the State of Louisiana, to its board of directors. Mr. Jindal was elected as the nation’ s youngest governor in 2007 and spent two terms as Louisiana’ s chief executive officer to rebuild and diversify the state’ s economy and financial footing in the aftermath of Hurricanes Katrina and Rita. Prior to serving as Governor, Mr. Jindal held positions as the head of the Louisiana Department of Health and Hospitals, President of the University of Louisiana System, Assistant Secretary of the U.S. Department of Health and Human Services, U.S. Congressman, and Executive Dire..."
09/14/2022 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
08/17/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/17/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/11/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/08/2022 EFFECT Form EFFECT - Notice of Effectiveness:
07/01/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
06/22/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/13/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/03/2022 EFFECT Form EFFECT - Notice of Effectiveness:
04/29/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/29/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/28/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/07/2022 10-K Annual Report for the period ended December 31, 2021
02/22/2022 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi...
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy